Managing Myeloma
- 2010-12-07 - Celgene plunges on concerns of secondary malignancies with blockbuster multiple myeloma drug Lenalidomide; news from Novo Nordisk, B-MS at ASH
- 2010-12-07 - 2nd UPDATE: Celgene Shares Drop On Concerns About Lenalidomide Data--The Wall Street Journal
- 2010-12-06 - ASH 2010 Multiple Myeloma Update – Day Two--The Myeloma Beacon
- 2010-12-05 - Carfilzomib Continues To Show Promising Results For Multiple Myeloma (ASH 2010)-The Myeloma Beacon
- 2010-12-05 - ASH 2010 Multiple Myeloma Update – Day One --The Myeloma Beacon
- 2010-12-05 - Continuous Treatment with Lenalidomide for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Evaluated by Intergroup Phase III Study (CALGB 100104)--Business Wire
- 2010-12-05 - ASH 2010 Update: Bendamustine + Prednisolone + Lenalidomide Well Tolerated in Patients With Refractory or Relapsed Multiple Myeloma-Monthly Prescribing Reference
- 2010-12-05 - ASH 2010 Update: Randomized Trials Needed to Determine Benefit of Thromboprophylaxis in Patients With Multiple Myeloma Receiving Thalidomide- or Lenalidomide-Based Regimens--Monthly Prescribing Regimens
- 2010-12-04 - ASH News Flash: Array BioPharma’s Arry-520 Demonstrates Single Agent Activity in Advanced Multiple Myeloma Patients
- 2010-12-04 - ASH News Flash: Phase III Study Evaluating Lenalidomide in Patients with High-Risk Smoldering Multiple Myeloma Reported Statistically Significant Reduction in Risk of Disease Progression -Celgene
- 2010-12-03 - Bone Drug May Help Treat Multiple Myeloma-Web MD
- 2010-12-03 - ASH News Flash---For the MMRC--Multiple Myeloma Research Consortium (MMRC) Honors University of Michigan with 2010 Center of the Year Award
- 2010-12-03 - ASH News Flash--For the IMF--The International Myeloma Foundation, Marking 20 Years of Serving the Myeloma Community, Applauds Members of the International Myeloma Working Group for Their Body of Work Being Presented at the ASH Hematology Conference
- 2010-12-02 - Karmanos to build $5M center -Detroit News
- 2010-12-01 - Array BioPharma to Present ARRY-520 / KSP Inhibitor Data at 2010 ASH Annual Meeting